Highlights Eli Lilly and Company London S.E.

Equities

LEL

US5324571083

Market Closed - London S.E. Other stock markets 09:37:36 2021-12-10 EST			5-day change	1st Jan Change
225.3 ^CHF	-1.50%		-58.28%	-58.28%

06-26	Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors	CI
06-25	Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Eli Lilly Working With OpenAI to Develop Medicines Against Drug-Resistant Pathogens	06-25	DJ
Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria	06-25	MT
Eli Lilly: collaboration agreement with OpenAI	06-25	CF
Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria	06-25	MT
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	06-25	DJ
Trending : Lilly Anti-Obesity Drug Tirzepatide Reduces Sleep Apnea Severity in Studies	06-24	DJ
Doctors must keep Ozempic prescriptions in check, Danish regulator says	06-24	RE
Eli Lilly Keeps Quarterly Dividend at $1.30 a Share, Payable Sept. 10 to Shareholders of Record on Aug. 15	06-24	MT
Eli Lilly and Company Declares Dividend for the Third Quarter of 2024, Payable on September 10, 2024	06-24	CI
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	06-24
What other health conditions are weight-loss drugs being tested for?	06-24	RE
Eli Lilly Weight-loss Drug Found to Benefit Obese Adults With Obstructive Sleep Apnea	06-22	MT
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar	06-21	RE
Eli Lilly and Company Announces Detailed Results from the Surmount-OSA Phase 3 Clinical Trials Evaluating Tirzepatide Injection	06-21	CI
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says	06-21	RE
Eli Lilly Sues More Wellness Centers, Medical Spas Over Unauthorized Tirzepatide Sales	06-21	MT
Health Care Stocks Rise Behind Gilead -- Health Care Roundup	06-20	DJ
Sector Update: Health Care Stocks Higher Late Afternoon	06-20	MT
Sector Update: Health Care	06-20	MT
Eli Lilly to 'Continue to Pursue Legal Remedies' Over Tirzepatide Product Claims	06-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm